NCT06363994 2024-12-27A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCLInnoCare Pharma Inc.Phase 3 Recruiting476 enrolled
NCT06496308 2024-07-11Bendamustine and Rituximab With or Without Orelabrutinib in MCL TreatmentRuijin HospitalPhase 3 Recruiting78 enrolled